HER2-positive breast cancers are rare amongst BRCA mutation carriers. No data exist regarding clinicopathological characteristics and prognosis of this subgroup of patients.
Viansone, A., Pellegrino, B., Omarini, C., Pistelli, M., Boggiani, D., Sikokis, A., et al. (2022). Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer. THE BREAST, 65, 145-150 [10.1016/j.breast.2022.07.012].
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer
Musolino, A
Ultimo
2022
Abstract
HER2-positive breast cancers are rare amongst BRCA mutation carriers. No data exist regarding clinicopathological characteristics and prognosis of this subgroup of patients.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Breast.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale / Version Of Record
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione
1.07 MB
Formato
Adobe PDF
|
1.07 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
